Genetic testing for rare diseases made more efficient and more accessible
Collaborated with 200+ entities across 45+ countries
We are committed to patient care from testing to treatment.
Provide clinical-grade testing
Whole exome sequencing-based testing is performed following the American College of Medical Genetics and Genomics (ACMG) standards and guidelines.
Speed up drug discovery
A team of dedicated scientists and engineers is actively conducting research for treatments.
Apply cutting-edge technology
Our AI and sequencing technologies enable us to improve testing efficiency and accessibility.
Follow up with more information
New findings are automatically added to our database, allowing us to reanalyze patient data daily and notify you if there are any new gene-disease associations or reclassified variants based on the latest evidence.
“The 3billion service is exceptional, the portal is very friendly and easy to use, and raw data is made available in no time. Overall, a highly satisfactory experience.”
Veronica Arora, MBBS, MS OBG, DNB OBG, DNB Medical Genetics
Associate Consultant @ Institute of Medical Genetics & Genomics, India
“Our collaboration with 3billion helped us in the genetic investigation of our patients with fast, reliable and easy to understand reports of WES datasets.”
Marcondes C. França, Jr., M.D., Ph.D.
Associate Professor, Neurology @ UNICAMP, Brazil
“The partnership with 3billion was extremely valuable in advancing research projects on rare congenital disease from my lab. The whole exome sequencing service provided was very fast, and a high molecular diagnosis was achieved (>50%).”
Ana Krepischi, Ph.D.
Assistant Professor, Genetics and Evolutionary Biology, Institute of Biosciences @ University of Sao Paulo, Brazil
“I give to our collaborators at 3billion a special gratitude for their outstanding services that helped in ending the diagnostic odyssey for many of our patients with rare diseases.”
Ngu Lock Hock, M.D.
Consultant Clinical Geneticist & Head of Medical Genetics @ Hospital Kuala Lumpur, Malaysia
“3billion has been very valuable for the care of my patients and the conduction of my research. The results are very informative and illustrative.”
Marwa Abd Elmaksoud, M.D.
Lecturer in Pediatrics and Pediatric Neurology & Faculty of Medicine @ Alexandria University Children's Hospital, Egypt
"3billion offers one of the most integrative services in genetic testing for rare diseases. Notably, the automated reanalysis tool for inconclusive cases is of extreme value for patient care.”
Juan Carlos Zenteno, M.D., Ph.D.
Head of Department of Genetics @ Institute of Ophthalmology "Conde de Valenciana," Mexico
“The 3billion service is exceptional, the portal is very friendly and easy to use, and raw data is made available in no time. Overall, a highly satisfactory experience.”
Veronica Arora, MBBS, MS OBG, DNB OBG, DNB Medical Genetics
Associate Consultant @ Institute of Medical Genetics & Genomics, India
“Our collaboration with 3billion helped us in the genetic investigation of our patients with fast, reliable and easy to understand reports of WES datasets.”
Marcondes C. França, Jr., M.D., Ph.D.
Associate Professor, Neurology @ UNICAMP, Brazil
“The partnership with 3billion was extremely valuable in advancing research projects on rare congenital disease from my lab. The whole exome sequencing service provided was very fast, and a high molecular diagnosis was achieved (>50%).”
Ana Krepischi, Ph.D.
Assistant Professor, Genetics and Evolutionary Biology, Institute of Biosciences @ University of Sao Paulo, Brazil
“I give to our collaborators at 3billion a special gratitude for their outstanding services that helped in ending the diagnostic odyssey for many of our patients with rare diseases.”
Ngu Lock Hock, M.D.
Consultant Clinical Geneticist & Head of Medical Genetics @ Hospital Kuala Lumpur, Malaysia
“3billion has been very valuable for the care of my patients and the conduction of my research. The results are very informative and illustrative.”
Marwa Abd Elmaksoud, M.D.
Lecturer in Pediatrics and Pediatric Neurology & Faculty of Medicine @ Alexandria University Children's Hospital, Egypt
"3billion offers one of the most integrative services in genetic testing for rare diseases. Notably, the automated reanalysis tool for inconclusive cases is of extreme value for patient care.”
Juan Carlos Zenteno, M.D., Ph.D.
Head of Department of Genetics @ Institute of Ophthalmology "Conde de Valenciana," Mexico
“The 3billion service is exceptional, the portal is very friendly and easy to use, and raw data is made available in no time. Overall, a highly satisfactory experience.”
Veronica Arora, MBBS, MS OBG, DNB OBG, DNB Medical Genetics
Associate Consultant @ Institute of Medical Genetics & Genomics, India
“Our collaboration with 3billion helped us in the genetic investigation of our patients with fast, reliable and easy to understand reports of WES datasets.”
Marcondes C. França, Jr., M.D., Ph.D.
Associate Professor, Neurology @ UNICAMP, Brazil
“The partnership with 3billion was extremely valuable in advancing research projects on rare congenital disease from my lab. The whole exome sequencing service provided was very fast, and a high molecular diagnosis was achieved (>50%).”
Ana Krepischi, Ph.D.
Assistant Professor, Genetics and Evolutionary Biology, Institute of Biosciences @ University of Sao Paulo, Brazil